Cervical intraepithelial neoplasia
Cervical Intraepithelial Neoplasia (CIN)[edit | edit source]
Cervical Intraepithelial Neoplasia (CIN) is a precancerous condition in which abnormal cell growth occurs on the surface of the cervix. CIN is classified based on the extent of cell abnormality and is an important indicator for the risk of developing cervical cancer. It is categorized into low-grade and high-grade lesions, reflecting the severity of the cellular atypia and architectural changes without evidence of stromal invasion.
Classification[edit | edit source]
CIN is classified into three grades, according to the degree of epithelial abnormality:
- CIN 1: Low-grade dysplasia, indicating mild abnormalities.
- CIN 2: Moderate dysplasia, considered high-grade but with lower risk than CIN 3.
- CIN 3: Severe dysplasia to carcinoma in situ, the highest precancerous stage.
Causes and Risk Factors[edit | edit source]
CIN is most commonly caused by persistent infection with high-risk types of Human Papillomavirus (HPV). Other risk factors include:
- Early sexual activity
- Multiple sexual partners
- Smoking
- Immunosuppression
Symptoms[edit | edit source]
CIN itself often presents no symptoms and is usually detected through routine cervical screening tests. If left untreated and progresses to cervical cancer, symptoms may include abnormal vaginal bleeding, pelvic pain, and pain during intercourse.
Diagnosis[edit | edit source]
Diagnosis of CIN involves:
- Pap smear tests: Screening for abnormal cells in the cervix.
- HPV testing: Identifying high-risk HPV strains.
- Colposcopy and biopsy: Further examination and tissue sampling if abnormal cells are found.
Treatment[edit | edit source]
Treatment depends on the grade of CIN:
- CIN 1: Often resolves spontaneously; regular monitoring is recommended.
- CIN 2 and CIN 3: May require more active treatment, such as cryotherapy, laser therapy, or surgical removal of the affected tissue.
Prevention and Screening[edit | edit source]
Preventive measures include HPV vaccination and regular cervical screening (Pap tests and HPV testing) to detect changes early. These strategies significantly reduce the incidence of cervical cancer.
See Also[edit | edit source]
References[edit | edit source]
- American Cancer Society. (2021). Cervical Cancer, HPV, and Cervical Dysplasia.
- World Health Organization. (2020). Human papillomavirus (HPV) and cervical cancer.
External Links[edit | edit source]
Cervical intraepithelial neoplasia Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Kondreddy Naveen